Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106478751B details a pyridine-free route for capecitabine intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111606917B discloses a scalable synthesis of C-ring fused abietane lactones. Discover cost-effective routes for high-purity oncology intermediates.
Discover the novel aqueous synthesis of Picoplatin (CAS 181630-15-9) described in CN101775040B. This method eliminates toxic solvents, improves yield, and ensures supply chain stability for pharmaceutical manufacturers.
Patent CN111592531B reveals optimized AKT inhibitor route offering significant cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing partners.
Discover the enzymatic synthesis route for Nilaparib intermediates described in CN111072550A. Achieve high purity and cost efficiency in API manufacturing with our advanced catalytic technologies.
Advanced purification technology for Gefitinib via salt-forming and recrystallization. Delivers >99.9% purity with reduced solvent waste for reliable API supply chains.
Patent CN106047950A details enzymatic reduction for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN109912620A details novel EGFR inhibitor synthesis. Offers scalable routes for pharmaceutical intermediates with improved purity and supply chain reliability for global buyers.
Patent CN110156816B details a novel synthesis route for tetrahydropyrazolopiperazine compounds, offering improved yield and synergistic anticancer potential for pharmaceutical supply chains.
Patent CN105237573B details a high-yield synthesis of Ersentinib salt. Discover cost reduction in API manufacturing and supply chain reliability for oncology intermediates.
Patent CN1942460A enables efficient one-pot taxane semi-synthesis reducing steps and costs for reliable API intermediate supply chains globally.
Patent CN113121424A details a micro-reactor process for Palbociclib intermediates, offering superior purity, safety, and scalable manufacturing capabilities.
Advanced synthesis of bendamustine key intermediates via patent CN102558069B. Offers superior purity, safety, and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112409431B reveals novel cytarabine structural analogs with superior oral bioavailability. Discover cost-effective manufacturing solutions for high-purity leukemia intermediates.
Novel synthesis of anti-rectal cancer triazole derivatives via click chemistry. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediate supplier capabilities.
Patent CN101628927A details a stereoselective route for Gemcitabine. Discover cost reduction in pharmaceutical manufacturing and high-purity oncology intermediates.
Novel selective PLK1 inhibitor synthesis with high metabolic stability. Reduces toxicity for oncology drug development. Reliable pharmaceutical intermediates supplier.
Patent CN1771254A reveals a streamlined Mannich reaction for nucleoside phosphorylase inhibitors, offering significant cost reduction and scalable supply chain solutions for API manufacturing.
Patent CN112939971A discloses pyrido[2,3-d]pyrimidin-7-one derivatives as potent NEDD8 inhibitors, offering new routes for cost-effective API manufacturing and supply chain stability.
Patent CN108047230B reveals a novel acridine salt photocatalytic route for Ponatinib. Discover cost-effective, high-purity API manufacturing solutions.